StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)

Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%

Bio-Techne gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Bio-Techne's gross profit for the twelve months ending Jun 30, 2026 was $799.07M, up 1.1% year over year. For fiscal 2026 it was $799.07M, up 1.1% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $799.07M in fiscal 2026.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jun 30, 2026$799.07M+1.1%
FY2025Jun 30, 2025$790.27M+2.7%
FY2024Jun 30, 2024$769.73M-0.0%
FY2023Jun 30, 2023$769.82M+1.8%
FY2022Jun 30, 2022$756.50M+19.5%
FY2021Jun 30, 2021$632.85M+31.0%
FY2020Jun 30, 2020$483.19M+2.0%
FY2019Jun 30, 2019$473.49M+9.6%
FY2018Jun 30, 2018$432.14M+15.4%
FY2017Jun 30, 2017$374.54M+11.3%
FY2016Jun 30, 2016$336.66M+9.6%
FY2015Jun 30, 2015$307.28M+22.2%
FY2014Jun 30, 2014$251.41M+8.8%
FY2013Jun 30, 2013$231.11M-2.0%
FY2012Jun 30, 2012$235.80M+4.8%
FY2011Jun 30, 2011$224.94M+5.0%
FY2010Jun 30, 2010$214.15M+2.9%
FY2009Jun 30, 2009$208.03M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$211.39M+6.3%
Q3 FY2026CQ1 2026Mar 31, 2026$208.29M-2.9%
Q2 FY2026CQ4 2025Dec 31, 2025$191.28M-1.3%
Q1 FY2026CQ3 2025Sep 30, 2025$188.11M+2.8%
Q4 FY2025CQ2 2025Jun 30, 2025$198.81M-2.2%
Q3 FY2025CQ1 2025Mar 31, 2025$214.56M+4.9%
Q2 FY2025CQ4 2024Dec 31, 2024$193.89M+9.8%
Q1 FY2025CQ3 2024Sep 30, 2024$183.02M-1.2%
Q4 FY2024CQ2 2024Jun 30, 2024$203.35M-0.7%
Q3 FY2024CQ1 2024Mar 31, 2024$204.60M+1.2%
Q2 FY2024CQ4 2023Dec 31, 2023$176.59M-3.7%
Q1 FY2024CQ3 2023Sep 30, 2023$185.19M+3.1%
Q4 FY2023CQ2 2023Jun 30, 2023$204.70M+2.2%
Q3 FY2023CQ1 2023Mar 31, 2023$202.16M+0.3%
Q2 FY2023CQ4 2022Dec 31, 2022$183.36M-0.2%
Q1 FY2023CQ3 2022Sep 30, 2022$179.60M+5.0%
Q4 FY2022CQ2 2022Jun 30, 2022$200.35M+13.9%
Q3 FY2022CQ1 2022Mar 31, 2022$201.46M+19.7%
Q2 FY2022CQ4 2021Dec 31, 2021$183.69M+21.7%
Q1 FY2022CQ3 2021Sep 30, 2021$171.00M+24.2%
Q4 FY2021CQ2 2021Jun 30, 2021$175.94M+55.3%
Q3 FY2021CQ1 2021Mar 31, 2021$168.27M+29.4%
Q2 FY2021CQ4 2020Dec 31, 2020$150.90M+24.3%
Q1 FY2021CQ3 2020Sep 30, 2020$137.73M+16.3%
Q4 FY2020CQ2 2020Jun 30, 2020$113.31M-11.7%
Q3 FY2020CQ1 2020Mar 31, 2020$130.06M+4.4%
Q2 FY2020CQ4 2019Dec 31, 2019$121.40M+7.4%
Q1 FY2020CQ3 2019Sep 30, 2019$118.41M+10.0%
Q4 FY2019CQ2 2019Jun 30, 2019$128.26M+5.0%
Q3 FY2019CQ1 2019Mar 31, 2019$124.61M+13.0%
Q2 FY2019CQ4 2018Dec 31, 2018$113.02M+11.0%
Q1 FY2019CQ3 2018Sep 30, 2018$107.60M+9.9%
Q4 FY2018CQ2 2018Jun 30, 2018$122.18M+19.4%
Q3 FY2018CQ1 2018Mar 31, 2018$110.26M+14.0%
Q2 FY2018CQ4 2017Dec 31, 2017$101.83M+15.5%
Q1 FY2018CQ3 2017Sep 30, 2017$97.87M+12.0%
Q4 FY2017CQ2 2017Jun 30, 2017$102.37M–
Q3 FY2017CQ1 2017Mar 31, 2017$96.68M–
Q2 FY2017CQ4 2016Dec 31, 2016$88.14M–
Q1 FY2017CQ3 2016Sep 30, 2016$87.35M–

More Bio-Techne figures

See a number that looks wrong?